TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

ALIMERA SCIENCES INC

Ophthalmology
Pharma

ALIMERA SCIENCES INC is a pharmaceutical company focused on Ophthalmology. Key products include ILUVIEN.

2014
Since
2
Drugs
-
Trials
1
Approved (2yr)

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Ophthalmology 100%
1 drugs Phase 1: 3

Pipeline Strength Pro

Loading...